Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CTLA-4
Pharma
Bristol Myers fails to beat AZ in stage 3 lung cancer
After flops by AstraZeneca and Bristol Myers in stage 3 NSCLC, market watchers are turning their attention to upcoming readouts from Merck and Roche.
Angus Liu
May 13, 2024 10:23am
BMS shoots for 1L liver cancer again with Opdivo, Yervoy combo
Mar 20, 2024 10:18am
BMS shows I-O duo's power in first-line colorectal cancer
Jan 20, 2024 10:00am
BMS, AZ settle cancer immunotherapy patent suits for $510M
Aug 1, 2023 10:09am
AstraZeneca's CTLA-4 drug treme finally snags its first approval
Oct 24, 2022 10:48am
